精工科技(002006.SZ):簽署總金額11.50億元碳纖維生產線合同
格隆匯9月26日丨精工科技(002006.SZ)公佈,2023年9月26日,公司已與吉林國興碳纖維有限公司(簡稱吉林國興)簽署了合同編號為GX230926027的《碳化線裝置購銷合同》,合同約定,公司分四期向吉林國興提供8條碳纖維生產線,最終總金額為11.50億元(含税)。其中,Ⅰ期金額2.35億元(含税),Ⅱ期金額3.40億元(含税),Ⅰ、Ⅱ期同時啟動,Ⅰ期設備將於2023年11月15日開始進場安裝,Ⅱ期設備具體進場安裝日期以吉林國興書面通知為準;Ⅲ、Ⅳ期設備具體啟動日期以吉林國興書面通知為準。同日,公司已收到吉林國興支付的合同訂金2000萬元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.